B-TEMIA announces closing of financing with Epic Capital Management

Appointment of Dr Sanjeev Sharma as Board Member

QUEBEC, May 5, 2015 /CNW Telbec/ - B-TEMIA Inc., a market leader in human augmentation, announced today the closing of a private placement with a group of Canadian private investors and the Toronto-based private healthcare fund, Epic Capital Management Inc., a boutique investment firm focused on Canadian small and mid-cap securities.  This new financing confirms a 60% increase in B-TEMIA's value creation over the last year.  B-TEMIA has developed a disruptive powered assistive walking device called Keeogo™ and intends to use the funding to extend product commercialization and seek US market approval.  "We are convinced that B-TEMIA offers a unique solution with a huge market potential; B-TEMIA will have multiple growth opportunities as their technology is introduced to new industries and markets." states Mr. David Fawcett, Portfolio Manager at Epic Capital Management Inc.

In addition, B-TEMIA has appointed Dr. Sanjeev Sharma to its Board of Directors adding valuable clinical and medical technology expertise. Dr. Sharma was the founding CEO, and is currently a Director of Wellpoint Health Services. During his 8 years of leadership, Wellpoint grew from a single office in 2005, to become one of Canada's largest and fastest growing occupational health and safety providers, providing clinical services to over 200,000 Canadians. Currently he is an active investor and entrepreneur, having supported multiple start-ups in the health care, and technology verticals.  "Mobility is fundamental for good health.  B-TEMIA's Keeogo™ is truly a breakthrough assistive device that will help millions of individuals around the globe stay mobile, live independently and improve their health. " comments Dr. Sanjeev Sharma.

"We are thrilled to receive the support of our private investors and Epic Capital as well as having the privilege to team up with a successful medical entrepreneur such as Dr. Sharma.  This represents further validation of the incredible market opportunity for Keeogo™", comments Mr. Stéphane Bédard, President and CEO of B-TEMIA. 

About B-TEMIA (www.b-temia.com)

B-TEMIA Inc. is a medical device manufacturer that develops and markets products in the growing market of human augmentation systems.  Based in Quebec City (Canada), B-TEMIA operates through two wholly-owned subsidiaries, B-TEMIA Health Inc. and B-TEMIA Military Inc.  B-TEMIA owns a patent-pending wearable dermoskeleton technology that restores, maintains or enhances the mobility of users.

About Keeogo^TM (www.keeogo.com)

Keeogo™ is a powered assistive walking device worn on the lower body that provides individuals with the leg power they need to walk more, better and keep on going throughout their day.  Keeogo™ is designed for individuals who have limited walking endurance or mobility issues resulting from muscle weakness, aging in general or due to a number of medical conditions including knee/hip osteoarthritis, multiple sclerosis and Parkinson's disease.

SOURCE B-TEMIA

Related Links

www.b-temia.com